Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information remained secret.
https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png00https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png2024-10-23 09:41:392024-10-23 09:41:39What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.